OTCMKTS:GTHP

Guided Therapeutics Stock Forecast, Price & News

$0.59
-0.04 (-6.35 %)
(As of 07/30/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.53
$0.64
50-Day Range
$0.48
$0.71
52-Week Range
$0.16
$1.00
Volume6,131 shs
Average Volume15,571 shs
Market Capitalization$7.85 million
P/E RatioN/A
Dividend YieldN/A
Beta0.83
30 days | 90 days | 365 days | Advanced Chart
Receive GTHP News and Ratings via Email

Sign-up to receive the latest news and ratings for Guided Therapeutics and its competitors with MarketBeat's FREE daily newsletter.


About Guided Therapeutics

Guided Therapeutics, Inc. engages in the development of medical devices. It focuses on the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. The company was founded by Shabbir Bakir Bambot and Richard L. Fowler on October 27, 1992 and is headquartered in Norcross, GA.

Headlines

Company Profile for Guided Therapeutics, Inc.
Company Profile for Guided Therapeutics, Inc.
October 26, 2020 |  businesswire.com
See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.33 out of 5 stars

Medical Sector

1923rd out of 2,223 stocks

Electromedical Equipment Industry

56th out of 65 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Guided Therapeutics (OTCMKTS:GTHP) Frequently Asked Questions

What stocks does MarketBeat like better than Guided Therapeutics?

Wall Street analysts have given Guided Therapeutics a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Guided Therapeutics wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Guided Therapeutics?

Guided Therapeutics saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 2,300 shares, an increase of 35.3% from the June 30th total of 1,700 shares. Based on an average trading volume of 7,100 shares, the days-to-cover ratio is currently 0.3 days.
View Guided Therapeutics' Short Interest
.

When is Guided Therapeutics' next earnings date?

Guided Therapeutics is scheduled to release its next quarterly earnings announcement on Wednesday, August 18th 2021.
View our earnings forecast for Guided Therapeutics
.

Who are Guided Therapeutics' key executives?

Guided Therapeutics' management team includes the following people:
  • Gene S. Cartwright, President, Chief Executive Officer, CFO & Director
  • Mark L. Faupel, Secretary, COO & Director
  • Richard L. Fowler, Senior Vice President-Engineering
  • Bill Wells, Communications Director

Who are some of Guided Therapeutics' key competitors?

What is Guided Therapeutics' stock symbol?

Guided Therapeutics trades on the OTCMKTS under the ticker symbol "GTHP."

How do I buy shares of Guided Therapeutics?

Shares of GTHP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Guided Therapeutics' stock price today?

One share of GTHP stock can currently be purchased for approximately $0.59.

How much money does Guided Therapeutics make?

Guided Therapeutics has a market capitalization of $7.85 million and generates $100,000.00 in revenue each year.

How many employees does Guided Therapeutics have?

Guided Therapeutics employs 6 workers across the globe.

What is Guided Therapeutics' official website?

The official website for Guided Therapeutics is www.guidedinc.com.

Where are Guided Therapeutics' headquarters?

Guided Therapeutics is headquartered at 5835 PEACHTREE CORNERS EAST SUITE D, PEACHTREE CORNERS GA, 30092.

How can I contact Guided Therapeutics?

Guided Therapeutics' mailing address is 5835 PEACHTREE CORNERS EAST SUITE D, PEACHTREE CORNERS GA, 30092. The company can be reached via phone at (770) 242-8723 or via email at [email protected]


This page was last updated on 7/31/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.